{
  "ticker": "CDX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02975452",
  "id": "02975452",
  "pages": 6,
  "price_sensitive": true,
  "date": "20250731",
  "time": "1626",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250731/pdf/06md7l3t9203zv.pdf",
  "summary": "### **Cardiex Limited \u2013 Quarterly Cash Flow Report (Appendix 4C) Summary**  \n\n#### **Key Highlights:**  \n- **Closing Cash Balance:** **$2.43M** (up from **$0.24M** previous quarter).  \n- **Net Cash Used in Operating Activities:** **($2.98M)** for the quarter, **($11.12M)** year-to-date.  \n- **Financing Activities:**  \n  - Raised **$5.37M** (placement & entitlements proceeds received in Q4).  \n  - Expects additional **$1.20M** in Q1 2026 from pending settlements.  \n  - Secured **$446k** additional drawdown under **R&D Term Loan Facility** (now at **16% interest**, due by **31 Oct 2025**).  \n- **Funding Runway:** **0.82 quarters** based on current burn rate (~3 months).  \n- **Debt & Liabilities:**  \n  - **$2.99M** loan facilities fully drawn.  \n  - **US$1.25M** remaining under **promissory note** (US legal fees, 5.5% interest, repayments through July 2026).  \n- **Operational Outlook:**  \n  - **Cost reductions (~30%)** from operational restructuring, expected to benefit FY26 cash flow.  \n  - **New revenue streams** (CONNEQT Pulse & App sales) contributing positively.  \n  - **Anticipated R&D tax refund (~$1.5M Oct 2025)** to repay R&D loan facility.  \n\n#### **Material Risks:**  \n- **Limited liquidity** (0.82 quarters funding); further capital raising or cost control critical.  \n- **High-interest debt** (16% on R&D loan, 5.5% on promissory note).  \n\n**Note:** No dividend payments or material investing activities.",
  "usage": {
    "prompt_tokens": 3908,
    "completion_tokens": 405,
    "total_tokens": 4313,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-31T06:32:07.707763"
}